BrosMed Artimes™ Semi-compliant PTCA Balloon Catheter was highly praised by professors and experts at RPR-CTO Summit 2018
Release time:
2018-06-28
23rd-24th June 2018, The Third China Summit for Retrograde Percutaneous Recanalization of Chronic Total Occlusion (RPR-CTO Summit 2018), which was hosted by Guangdong Medical Doctor Association and Guangdong Interventional Cardiology Association and organized by Guangdong People’ Hospital, was successfully convened at Dong Fang Hotel, Guangzhou China.
23rd-24th June 2018, The Third China Summit for Retrograde Percutaneous Recanalization of Chronic Total Occlusion (RPR-CTO Summit 2018), which was hosted by Guangdong Medical Doctor Association and Guangdong Interventional Cardiology Association and organized by Guangdong People’ Hospital, was successfully convened at Dong Fang Hotel, Guangzhou China. ArtimesTM Semi-compliant PTCA Balloon Catheter was highly praised by executive chairmen professor Bin Zhang, and professor Quanmin Jing, as well as other experts attended the summit.
Professor Bin Zhang from Guangdong People’ Hospital, professor Lei Ge from Zhongshan Hospital affiliated to Fudan University, professor Quanmin Jing from General Hospital of Shenyang Military Region and professor Chengxiang Li From Xijing Hospital, were elected to be executive chairmen for RPR-CTO Summit 2018. Besides which, several internationally renowned interventional therapy experts were also invited to this summit to share their clinical experience and operation skills. During live broadcast operation case, BrosMed ArtimesTM Semi-compliant PTCA Balloon Catheter was widely praised by two professors and other experts because of its excellent crossibility and flexibility.
The factor drives Chinese CTO therapy into maturity is that not only the improvement of the surgeon’s skills and the accumulation of experience, but also the continuous improvement of the production technology and the innovation of products of medical device companies. BrosMed Medical, as a Chinese domestic brand, constantly improves and perfects its ability in technology development and operation management in accordance with international standards. BrosMed strives to maintain a competitive position in the global high-end medical device consumables market, and provides better, more effective and convenient medical devices for patients and doctors.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
BrosMed Medical product portfolio consist of
Artimes™ PTCA balloon catheter
Apollo™ NC PTCA balloon catheter
Wedge™ Semi-complaint Scoring PTCA balloon catheter
Atropos™ 0.035 PTA balloon catheter
Minerva™ 0.018PTA balloon catheter
Polux™ 0.014 PTA balloon catheter
Hermes™ NC 0.035 PTA balloon catheter
Achilles™ NC 0.018PTA balloon catheter
Castor™ NC 0.014 PTA balloon catheter
Conger™ Hydrophilic coated guidewire
Freepath™ Catheter Sheath Introducer
BrosMed Medical is supplying safe, effective and hi-tech medical devices in 40 countries.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27